Yongming Cai
Overview
Explore the profile of Yongming Cai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
97
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen J, Han F, He M, Shi Y, Cai Y
BMC Bioinformatics
. 2025 Feb;
26(1):54.
PMID: 39962381
Adverse drug reactions (ADRs) are among the global public health events that seriously endanger human life and cause high economic burdens. Therefore, predicting the possibility of their occurrence and taking...
2.
Jiang J, Wu H, Jiang X, Ou Q, Gan Z, Han F, et al.
Pharmaceuticals (Basel)
. 2025 Jan;
17(12.
PMID: 39770551
Background: Hepatocellular carcinoma (HCC), a prevalent form of primary liver malignancy, arises from liver-specific hepatocytes. Buch.-Ham(Climbing senecio) is a bitter-tasting plant of the Compositae family with anti-tumor properties. This study...
3.
Shi Y, He M, Chen J, Han F, Cai Y
PLoS Comput Biol
. 2024 Apr;
20(4):e1011989.
PMID: 38626249
Biomedical texts provide important data for investigating drug-drug interactions (DDIs) in the field of pharmacovigilance. Although researchers have attempted to investigate DDIs from biomedical texts and predict unknown DDIs, the...
4.
Liu R, Huang B, Shao Y, Cai Y, Liu X, Ren Z
J Transl Med
. 2023 Sep;
21(1):648.
PMID: 37735667
Background: Memory B cells and microRNAs (miRNAs) play important roles in the progression of gastric adenocarcinoma (GAC), also known as stomach adenocarcinoma (STAD). However, few studies have investigated the use...
5.
Zhou R, Lu P, He M, Chen J, Shi Y, Han F, et al.
Expert Opin Drug Saf
. 2023 Sep;
23(3):363-371.
PMID: 37665052
Background: The association between anti-vascular endothelial growth factor (VEGF) drugs and ocular adverse events (AEs) has been reported, but large real-world studies of their association with systemic AEs are still...
6.
Qu X, Du G, Hu J, Cai Y
Curr Comput Aided Drug Des
. 2023 Jul;
20(6):1013-1024.
PMID: 37448360
Background: In this study, we aimed to develop a new end-to-end learning model called Graph-Drug-Target Interaction (DTI), which integrates various types of information in the heterogeneous network data, and to...
7.
Ye L, Chen Y, Cai Y, Kao Y, Wang Y, Chen M, et al.
J Health Commun
. 2023 Mar;
28(4):231-240.
PMID: 36942570
The use of social media has changed since the outbreak of coronavirus disease 2019 (COVID-19). However, little is known about the gender disparity in social media use for nonspecific and...
8.
Hu L, Fu C, Ren Z, Cai Y, Yang J, Xu S, et al.
BMC Bioinformatics
. 2023 Feb;
24(1):38.
PMID: 36737694
Background: The experimental verification of a drug discovery process is expensive and time-consuming. Therefore, efficiently and effectively identifying drug-target interactions (DTIs) has been the focus of research. At present, many...
9.
Zeng Y, Gao M, Lin D, Du G, Cai Y
Biomed Res Int
. 2022 Feb;
2022:2592962.
PMID: 35178444
Background: Matrix metalloproteinase-9 (MMP-9) can degrade the extracellular matrix and participate in tumor progression. The relationship between MMP-9 and immune cells has been reported in various malignant tumors. However, there...
10.
Zeng Y, Lin D, Gao M, Du G, Cai Y
Sci Rep
. 2022 Feb;
12(1):1933.
PMID: 35121770
The protein PDLIM2 regulates the stability of various transcription factors and is required for polarized cell migration. However, the clinical relevance and immune infiltration of PDLIM2 in cancer are not...